Global Transdermal Skin Patch Sales Market Report 2024
The global Transdermal Skin Patch market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Transdermal Skin Patch market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Fentanyl Transdermal Skin Patch
Nicotine Transdermal Skin Patch
Clonidine Transdermal Skin Patch
Buprenorphine Transdermal Skin Patch
Segment by Application
Relieve Severe Pain
Stop Smoking Cigarettes
Treat an Overactive Bladder
Others
The Transdermal Skin Patch market is analysed and market size information is provided by regions (countries).
Segment by Application
, the Transdermal Skin Patch market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Hisamitsu Pharmaceutical
Novartis
Johnson & Johnson
Teikoku Pharma
Mylan
Actavis
Mundipharma
Henan Lingrui Pharmaceutical
Changzhou Siyao
Rfl Pharmaceutical
Luye Pharma Group Ltd.
Purdue Pharma L.P.
Teva Pharmaceutical Industries Ltd.
Table of Content
1 Transdermal Skin Patch Market Overview
1.1 Transdermal Skin Patch Product Scope
1.2 Transdermal Skin Patch Segment by Type
1.2.1 Global Transdermal Skin Patch Sales by Type (2016 & 2021 & 2027)
1.2.2 Fentanyl Transdermal Skin Patch
1.2.3 Nicotine Transdermal Skin Patch
1.2.4 Clonidine Transdermal Skin Patch
1.2.5 Buprenorphine Transdermal Skin Patch
1.3 Transdermal Skin Patch Segment by Application
1.3.1 Global Transdermal Skin Patch Sales Comparison by Application (2016 & 2021 & 2027)
1.3.2 Relieve Severe Pain
1.3.3 Stop Smoking Cigarettes
1.3.4 Treat an Overactive Bladder
1.3.5 Others
1.4 Transdermal Skin Patch Market Estimates and Forecasts (2016-2027)
1.4.1 Global Transdermal Skin Patch Market Size in Value Growth Rate (2016-2027)
1.4.2 Global Transdermal Skin Patch Market Size in Volume Growth Rate (2016-2027)
1.4.3 Global Transdermal Skin Patch Price Trends (2016-2027)
2 Transdermal Skin Patch Estimates and Forecasts by Region
2.1 Global Transdermal Skin Patch Market Size by Region: 2016 VS 2021 VS 2027
2.2 Global Transdermal Skin Patch Retrospective Market Scenario by Region (2016-2021)
2.2.1 Global Transdermal Skin Patch Sales Market Share by Region (2016-2021)
2.2.2 Global Transdermal Skin Patch Revenue Market Share by Region (2016-2021)
2.3 Global Transdermal Skin Patch Market Estimates and Forecasts by Region (2022-2027)
2.3.1 Global Transdermal Skin Patch Sales Estimates and Forecasts by Region (2022-2027)
2.3.2 Global Transdermal Skin Patch Revenue Forecast by Region (2022-2027)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 North America Transdermal Skin Patch Estimates and Projections (2016-2027)
2.4.2 Europe Transdermal Skin Patch Estimates and Projections (2016-2027)
2.4.3 China Transdermal Skin Patch Estimates and Projections (2016-2027)
2.4.4 Japan Transdermal Skin Patch Estimates and Projections (2016-2027)
2.4.5 Southeast Asia Transdermal Skin Patch Estimates and Projections (2016-2027)
2.4.6 India Transdermal Skin Patch Estimates and Projections (2016-2027)
3 Global Transdermal Skin Patch Competition Landscape by Players
3.1 Global Top Transdermal Skin Patch Players by Sales (2016-2021)
3.2 Global Top Transdermal Skin Patch Players by Revenue (2016-2021)
3.3 Global Transdermal Skin Patch Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Transdermal Skin Patch as of 2020)
3.4 Global Transdermal Skin Patch Average Price by Company (2016-2021)
3.5 Manufacturers Transdermal Skin Patch Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Global Transdermal Skin Patch Market Size by Type
4.1 Global Transdermal Skin Patch Historic Market Review by Type (2016-2021)
4.1.1 Global Transdermal Skin Patch Sales Market Share by Type (2016-2021)
4.1.2 Global Transdermal Skin Patch Revenue Market Share by Type (2016-2021)
4.1.3 Global Transdermal Skin Patch Price by Type (2016-2021)
4.2 Global Transdermal Skin Patch Market Estimates and Forecasts by Type (2022-2027)
4.2.1 Global Transdermal Skin Patch Sales Forecast by Type (2022-2027)
4.2.2 Global Transdermal Skin Patch Revenue Forecast by Type (2022-2027)
4.2.3 Global Transdermal Skin Patch Price Forecast by Type (2022-2027)
5 Global Transdermal Skin Patch Market Size by Application
5.1 Global Transdermal Skin Patch Historic Market Review by Application (2016-2021)
5.1.1 Global Transdermal Skin Patch Sales Market Share by Application (2016-2021)
5.1.2 Global Transdermal Skin Patch Revenue Market Share by Application (2016-2021)
5.1.3 Global Transdermal Skin Patch Price by Application (2016-2021)
5.2 Global Transdermal Skin Patch Market Estimates and Forecasts by Application (2022-2027)
5.2.1 Global Transdermal Skin Patch Sales Forecast by Application (2022-2027)
5.2.2 Global Transdermal Skin Patch Revenue Forecast by Application (2022-2027)
5.2.3 Global Transdermal Skin Patch Price Forecast by Application (2022-2027)
6 North America Transdermal Skin Patch Market Facts & Figures
6.1 North America Transdermal Skin Patch Sales by Company
6.1.1 North America Transdermal Skin Patch Sales by Company (2016-2021)
6.1.2 North America Transdermal Skin Patch Revenue by Company (2016-2021)
6.2 North America Transdermal Skin Patch Sales Breakdown by Type
6.2.1 North America Transdermal Skin Patch Sales Breakdown by Type (2016-2021)
6.2.2 North America Transdermal Skin Patch Sales Breakdown by Type (2022-2027)
6.3 North America Transdermal Skin Patch Sales Breakdown by Application
6.3.1 North America Transdermal Skin Patch Sales Breakdown by Application (2016-2021)
6.3.2 North America Transdermal Skin Patch Sales Breakdown by Application (2022-2027)
7 Europe Transdermal Skin Patch Market Facts & Figures
7.1 Europe Transdermal Skin Patch Sales by Company
7.1.1 Europe Transdermal Skin Patch Sales by Company (2016-2021)
7.1.2 Europe Transdermal Skin Patch Revenue by Company (2016-2021)
7.2 Europe Transdermal Skin Patch Sales Breakdown by Type
7.2.1 Europe Transdermal Skin Patch Sales Breakdown by Type (2016-2021)
7.2.2 Europe Transdermal Skin Patch Sales Breakdown by Type (2022-2027)
7.3 Europe Transdermal Skin Patch Sales Breakdown by Application
7.3.1 Europe 127 Sales Breakdown by Application (2016-2021)
7.3.2 Europe 127 Sales Breakdown by Application (2022-2027)
8 China Transdermal Skin Patch Market Facts & Figures
8.1 China Transdermal Skin Patch Sales by Company
8.1.1 China Transdermal Skin Patch Sales by Company (2016-2021)
8.1.2 China Transdermal Skin Patch Revenue by Company (2016-2021)
8.2 China Transdermal Skin Patch Sales Breakdown by Type
8.2.1 China Transdermal Skin Patch Sales Breakdown by Type (2016-2021)
8.2.2 China Transdermal Skin Patch Sales Breakdown by Type (2022-2027)
8.3 China Transdermal Skin Patch Sales Breakdown by Application
8.3.1 China 155 Sales Breakdown by Application (2016-2021)
8.3.2 China 155 Sales Breakdown by Application (2022-2027)
9 Japan Transdermal Skin Patch Market Facts & Figures
9.1 Japan Transdermal Skin Patch Sales by Company
9.1.1 Japan Transdermal Skin Patch Sales by Company (2016-2021)
9.1.2 Japan Transdermal Skin Patch Revenue by Company (2016-2021)
9.2 Japan Transdermal Skin Patch Sales Breakdown by Type
9.2.1 Japan Transdermal Skin Patch Sales Breakdown by Type (2016-2021)
9.2.2 Japan Transdermal Skin Patch Sales Breakdown by Type (2022-2027)
9.3 Japan Transdermal Skin Patch Sales Breakdown by Application
9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021)
9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027)
10 Southeast Asia Transdermal Skin Patch Market Facts & Figures
10.1 Southeast Asia Transdermal Skin Patch Sales by Company
10.1.1 Southeast Asia Transdermal Skin Patch Sales by Company (2016-2021)
10.1.2 Southeast Asia Transdermal Skin Patch Revenue by Company (2016-2021)
10.2 Southeast Asia Transdermal Skin Patch Sales Breakdown by Type
10.2.1 Southeast Asia Transdermal Skin Patch Sales Breakdown by Type (2016-2021)
10.2.2 Southeast Asia Transdermal Skin Patch Sales Breakdown by Type (2022-2027)
10.3 Southeast Asia Transdermal Skin Patch Sales Breakdown by Application
10.3.1 Southeast Asia K Units Sales Breakdown by Application (2016-2021)
10.3.2 Southeast Asia K Units Sales Breakdown by Application (2022-2027)
11 India Transdermal Skin Patch Market Facts & Figures
11.1 India Transdermal Skin Patch Sales by Company
11.1.1 India Transdermal Skin Patch Sales by Company (2016-2021)
11.1.2 India Transdermal Skin Patch Revenue by Company (2016-2021)
11.2 India Transdermal Skin Patch Sales Breakdown by Type
11.2.1 India Transdermal Skin Patch Sales Breakdown by Type (2016-2021)
11.2.2 India Transdermal Skin Patch Sales Breakdown by Type (2022-2027)
11.3 India Transdermal Skin Patch Sales Breakdown by Application
11.3.1 India Transdermal Skin Patch Sales Breakdown by Application (2016-2021)
11.3.2 India Transdermal Skin Patch Sales Breakdown by Application (2022-2027)
12 Company Profiles and Key Figures in Transdermal Skin Patch Business
12.1 Hisamitsu Pharmaceutical
12.1.1 Hisamitsu Pharmaceutical Corporation Information
12.1.2 Hisamitsu Pharmaceutical Business Overview
12.1.3 Hisamitsu Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.1.4 Hisamitsu Pharmaceutical Transdermal Skin Patch Products Offered
12.1.5 Hisamitsu Pharmaceutical Recent Development
12.2 Novartis
12.2.1 Novartis Corporation Information
12.2.2 Novartis Business Overview
12.2.3 Novartis Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Novartis Transdermal Skin Patch Products Offered
12.2.5 Novartis Recent Development
12.3 Johnson & Johnson
12.3.1 Johnson & Johnson Corporation Information
12.3.2 Johnson & Johnson Business Overview
12.3.3 Johnson & Johnson Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Johnson & Johnson Transdermal Skin Patch Products Offered
12.3.5 Johnson & Johnson Recent Development
12.4 Teikoku Pharma
12.4.1 Teikoku Pharma Corporation Information
12.4.2 Teikoku Pharma Business Overview
12.4.3 Teikoku Pharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Teikoku Pharma Transdermal Skin Patch Products Offered
12.4.5 Teikoku Pharma Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Mylan Transdermal Skin Patch Products Offered
12.5.5 Mylan Recent Development
12.6 Actavis
12.6.1 Actavis Corporation Information
12.6.2 Actavis Business Overview
12.6.3 Actavis Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Actavis Transdermal Skin Patch Products Offered
12.6.5 Actavis Recent Development
12.7 Mundipharma
12.7.1 Mundipharma Corporation Information
12.7.2 Mundipharma Business Overview
12.7.3 Mundipharma Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Mundipharma Transdermal Skin Patch Products Offered
12.7.5 Mundipharma Recent Development
12.8 Henan Lingrui Pharmaceutical
12.8.1 Henan Lingrui Pharmaceutical Corporation Information
12.8.2 Henan Lingrui Pharmaceutical Business Overview
12.8.3 Henan Lingrui Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Henan Lingrui Pharmaceutical Transdermal Skin Patch Products Offered
12.8.5 Henan Lingrui Pharmaceutical Recent Development
12.9 Changzhou Siyao
12.9.1 Changzhou Siyao Corporation Information
12.9.2 Changzhou Siyao Business Overview
12.9.3 Changzhou Siyao Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Changzhou Siyao Transdermal Skin Patch Products Offered
12.9.5 Changzhou Siyao Recent Development
12.10 Rfl Pharmaceutical
12.10.1 Rfl Pharmaceutical Corporation Information
12.10.2 Rfl Pharmaceutical Business Overview
12.10.3 Rfl Pharmaceutical Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.10.4 Rfl Pharmaceutical Transdermal Skin Patch Products Offered
12.10.5 Rfl Pharmaceutical Recent Development
12.11 Luye Pharma Group Ltd.
12.11.1 Luye Pharma Group Ltd. Corporation Information
12.11.2 Luye Pharma Group Ltd. Business Overview
12.11.3 Luye Pharma Group Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.11.4 Luye Pharma Group Ltd. Transdermal Skin Patch Products Offered
12.11.5 Luye Pharma Group Ltd. Recent Development
12.12 Purdue Pharma L.P.
12.12.1 Purdue Pharma L.P. Corporation Information
12.12.2 Purdue Pharma L.P. Business Overview
12.12.3 Purdue Pharma L.P. Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.12.4 Purdue Pharma L.P. Transdermal Skin Patch Products Offered
12.12.5 Purdue Pharma L.P. Recent Development
12.13 Teva Pharmaceutical Industries Ltd.
12.13.1 Teva Pharmaceutical Industries Ltd. Corporation Information
12.13.2 Teva Pharmaceutical Industries Ltd. Business Overview
12.13.3 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Sales, Revenue and Gross Margin (2016-2021)
12.13.4 Teva Pharmaceutical Industries Ltd. Transdermal Skin Patch Products Offered
12.13.5 Teva Pharmaceutical Industries Ltd. Recent Development
13 Transdermal Skin Patch Manufacturing Cost Analysis
13.1 Transdermal Skin Patch Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Transdermal Skin Patch
13.4 Transdermal Skin Patch Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Transdermal Skin Patch Distributors List
14.3 Transdermal Skin Patch Customers
15 Market Dynamics
15.1 Transdermal Skin Patch Market Trends
15.2 Transdermal Skin Patch Drivers
15.3 Transdermal Skin Patch Market Challenges
15.4 Transdermal Skin Patch Market Restraints
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer